Market Currents
Medtronic's (MDT) business for neuromodulation devices received an FDA warning letter related...
-
Tuesday, August 21, 2012, 9:17 AM ETMedtronic's (MDT) business for neuromodulation devices received an FDA warning letter related mainly to the company's processes for handling complaints, MDT CFO Gary Ellis disclosed in a conference call, adding that he does not expect a material impact on financial results. (earlier: FQ1 results)
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
